Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same
US11027009B2 · kind B2 · utility
0Cited by
70References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2020 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | May 12, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions, recombinant vaccines and live attenuated pathogens comprising one or more isolated nucleic acid molecules that encode an immunogen in combination with an isolated nucleic acid molecule that encodes IL-28 or a functional fragment thereof are disclosed. Methods of inducing an immune response in an individual against an immunogen, using such compositions are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.